HEADER TRANSCRIPTION 01-FEB-17 5UOO TITLE BRD4 BROMODOMAIN 2 IN COMPLEX WITH CD161 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN-CONTAINING PROTEIN 4; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 333-460; COMPND 5 SYNONYM: PROTEIN HUNK1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRD4, HUNK1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS BROMODOMAIN, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR J.L.MEAGHER,J.A.STUCKEY REVDAT 3 22-NOV-17 5UOO 1 REMARK REVDAT 2 24-MAY-17 5UOO 1 JRNL REMARK REVDAT 1 17-MAY-17 5UOO 0 JRNL AUTH Y.ZHAO,L.BAI,L.LIU,D.MCEACHERN,J.A.STUCKEY,J.L.MEAGHER, JRNL AUTH 2 C.Y.YANG,X.RAN,B.ZHOU,Y.HU,X.LI,B.WEN,T.ZHAO,S.LI,D.SUN, JRNL AUTH 3 S.WANG JRNL TITL STRUCTURE-BASED DISCOVERY OF JRNL TITL 2 4-(6-METHOXY-2-METHYL-4-(QUINOLIN-4-YL)-9H-PYRIMIDO[4, JRNL TITL 3 5-B]INDOL-7-YL)-3,5-DIMETHYLISOXAZOLE (CD161) AS A POTENT JRNL TITL 4 AND ORALLY BIOAVAILABLE BET BROMODOMAIN INHIBITOR. JRNL REF J. MED. CHEM. V. 60 3887 2017 JRNL REFN ISSN 1520-4804 JRNL PMID 28463487 JRNL DOI 10.1021/ACS.JMEDCHEM.7B00193 REMARK 2 REMARK 2 RESOLUTION. 1.69 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.69 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.38 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 3 NUMBER OF REFLECTIONS : 13979 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.176 REMARK 3 R VALUE (WORKING SET) : 0.175 REMARK 3 FREE R VALUE : 0.196 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.060 REMARK 3 FREE R VALUE TEST SET COUNT : 707 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.000 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 7 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.69 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.82 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.58 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2731 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1710 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2587 REMARK 3 BIN R VALUE (WORKING SET) : 0.1690 REMARK 3 BIN FREE R VALUE : 0.2020 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.27 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 144 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 912 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 33 REMARK 3 SOLVENT ATOMS : 105 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 20.32 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.32 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.03730 REMARK 3 B22 (A**2) : 2.49830 REMARK 3 B33 (A**2) : -0.46100 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.200 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.108 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.097 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.099 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.092 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.951 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.944 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 1031 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 1418 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 460 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 25 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 207 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 1031 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 119 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 1311 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 0.86 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.14 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 2.61 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 7 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: {A|348 - 376} REMARK 3 ORIGIN FOR THE GROUP (A): 9.7855 11.0858 1.5308 REMARK 3 T TENSOR REMARK 3 T11: -0.0403 T22: -0.0240 REMARK 3 T33: -0.0375 T12: -0.0263 REMARK 3 T13: -0.0025 T23: -0.0129 REMARK 3 L TENSOR REMARK 3 L11: 2.2269 L22: 3.5776 REMARK 3 L33: 2.6742 L12: -1.3854 REMARK 3 L13: 1.0131 L23: -1.6660 REMARK 3 S TENSOR REMARK 3 S11: -0.0017 S12: 0.0772 S13: 0.0252 REMARK 3 S21: -0.0294 S22: 0.0108 S23: 0.0392 REMARK 3 S31: -0.0857 S32: 0.0672 S33: -0.0090 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: {A|377 - 383} REMARK 3 ORIGIN FOR THE GROUP (A): 21.6094 -3.2992 2.1692 REMARK 3 T TENSOR REMARK 3 T11: -0.0357 T22: 0.0366 REMARK 3 T33: 0.0775 T12: 0.0102 REMARK 3 T13: -0.0079 T23: -0.0019 REMARK 3 L TENSOR REMARK 3 L11: 1.0553 L22: 0.2387 REMARK 3 L33: 0.0000 L12: -1.1075 REMARK 3 L13: -0.3509 L23: -0.6119 REMARK 3 S TENSOR REMARK 3 S11: 0.0141 S12: -0.1128 S13: -0.2750 REMARK 3 S21: 0.0101 S22: -0.0368 S23: -0.2627 REMARK 3 S31: -0.0727 S32: 0.2464 S33: 0.0227 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: {A|384 - 402} REMARK 3 ORIGIN FOR THE GROUP (A): 16.7801 -8.6649 -0.8293 REMARK 3 T TENSOR REMARK 3 T11: -0.0379 T22: -0.0149 REMARK 3 T33: -0.0087 T12: 0.0155 REMARK 3 T13: -0.0043 T23: -0.0099 REMARK 3 L TENSOR REMARK 3 L11: 0.3177 L22: 6.3279 REMARK 3 L33: 0.0000 L12: -1.1760 REMARK 3 L13: -0.0258 L23: -0.7373 REMARK 3 S TENSOR REMARK 3 S11: 0.0465 S12: 0.0452 S13: -0.0239 REMARK 3 S21: -0.2790 S22: -0.0690 S23: -0.3898 REMARK 3 S31: 0.0567 S32: 0.1053 S33: 0.0224 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: {A|403 - 410} REMARK 3 ORIGIN FOR THE GROUP (A): 14.9622 8.4720 -8.6245 REMARK 3 T TENSOR REMARK 3 T11: 0.0324 T22: 0.0549 REMARK 3 T33: -0.0347 T12: -0.0294 REMARK 3 T13: 0.0029 T23: -0.0019 REMARK 3 L TENSOR REMARK 3 L11: 1.1211 L22: 1.0525 REMARK 3 L33: 2.4419 L12: -1.0583 REMARK 3 L13: -2.6777 L23: 1.1180 REMARK 3 S TENSOR REMARK 3 S11: -0.0374 S12: 0.0277 S13: -0.1197 REMARK 3 S21: -0.1663 S22: -0.0267 S23: -0.0795 REMARK 3 S31: -0.2106 S32: 0.0087 S33: 0.0641 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 SELECTION: {A|411 - 435} REMARK 3 ORIGIN FOR THE GROUP (A): 7.2274 -1.3072 -2.2430 REMARK 3 T TENSOR REMARK 3 T11: -0.0429 T22: -0.0187 REMARK 3 T33: -0.0281 T12: -0.0014 REMARK 3 T13: -0.0029 T23: -0.0221 REMARK 3 L TENSOR REMARK 3 L11: 1.0172 L22: 1.6045 REMARK 3 L33: 0.9219 L12: -0.3021 REMARK 3 L13: -0.0642 L23: -0.2864 REMARK 3 S TENSOR REMARK 3 S11: 0.0743 S12: 0.1169 S13: -0.1377 REMARK 3 S21: 0.0210 S22: -0.0244 S23: 0.1450 REMARK 3 S31: -0.0759 S32: 0.0465 S33: -0.0500 REMARK 3 REMARK 3 TLS GROUP : 6 REMARK 3 SELECTION: {A|436 - 443} REMARK 3 ORIGIN FOR THE GROUP (A): 10.3699 -4.7323 12.9273 REMARK 3 T TENSOR REMARK 3 T11: -0.0071 T22: 0.0410 REMARK 3 T33: -0.0205 T12: -0.0116 REMARK 3 T13: -0.0152 T23: 0.0205 REMARK 3 L TENSOR REMARK 3 L11: 0.0002 L22: 1.2320 REMARK 3 L33: 1.8032 L12: 0.3407 REMARK 3 L13: 0.5432 L23: 1.2768 REMARK 3 S TENSOR REMARK 3 S11: 0.0381 S12: -0.1977 S13: -0.0180 REMARK 3 S21: 0.1293 S22: -0.0437 S23: -0.1304 REMARK 3 S31: 0.2674 S32: 0.0581 S33: 0.0056 REMARK 3 REMARK 3 TLS GROUP : 7 REMARK 3 SELECTION: {A|444 - 460} REMARK 3 ORIGIN FOR THE GROUP (A): 0.8156 8.5918 2.5614 REMARK 3 T TENSOR REMARK 3 T11: -0.0294 T22: 0.0007 REMARK 3 T33: -0.0001 T12: -0.0047 REMARK 3 T13: 0.0046 T23: 0.0034 REMARK 3 L TENSOR REMARK 3 L11: 2.4105 L22: 3.0171 REMARK 3 L33: 4.6101 L12: -1.3168 REMARK 3 L13: 1.3783 L23: -2.2135 REMARK 3 S TENSOR REMARK 3 S11: 0.0563 S12: 0.0462 S13: 0.1751 REMARK 3 S21: 0.0001 S22: 0.0891 S23: 0.1547 REMARK 3 S31: -0.1306 S32: -0.1277 S33: -0.1454 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5UOO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-FEB-17. REMARK 100 THE DEPOSITION ID IS D_1000226181. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-NOV-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-G REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9786 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-300 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000, DENZO REMARK 200 DATA SCALING SOFTWARE : HKL-2000, SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14010 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.690 REMARK 200 RESOLUTION RANGE LOW (A) : 29.380 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 200 DATA REDUNDANCY : 6.100 REMARK 200 R MERGE (I) : 0.07100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.73 REMARK 200 COMPLETENESS FOR SHELL (%) : 87.1 REMARK 200 DATA REDUNDANCY IN SHELL : 5.50 REMARK 200 R MERGE FOR SHELL (I) : 0.41800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.44 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 60% PEG 400, 0.1M IMIDIZOLE, 5MM ATP, REMARK 280 PH 8.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 26.09400 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.39650 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.09400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.39650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 686 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 330 REMARK 465 ASN A 331 REMARK 465 ALA A 332 REMARK 465 LYS A 333 REMARK 465 ASP A 334 REMARK 465 VAL A 335 REMARK 465 PRO A 336 REMARK 465 ASP A 337 REMARK 465 SER A 338 REMARK 465 GLN A 339 REMARK 465 GLN A 340 REMARK 465 HIS A 341 REMARK 465 PRO A 342 REMARK 465 ALA A 343 REMARK 465 PRO A 344 REMARK 465 GLU A 345 REMARK 465 LYS A 346 REMARK 465 SER A 347 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 348 OG REMARK 470 LYS A 349 CG CD CE NZ REMARK 470 LYS A 367 CD CE NZ REMARK 470 LYS A 395 CD CE NZ REMARK 470 ARG A 410 CG CD NE CZ NH1 NH2 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8FV A 501 DBREF 5UOO A 333 460 UNP O60885 BRD4_HUMAN 333 460 SEQADV 5UOO SER A 330 UNP O60885 EXPRESSION TAG SEQADV 5UOO ASN A 331 UNP O60885 EXPRESSION TAG SEQADV 5UOO ALA A 332 UNP O60885 EXPRESSION TAG SEQRES 1 A 131 SER ASN ALA LYS ASP VAL PRO ASP SER GLN GLN HIS PRO SEQRES 2 A 131 ALA PRO GLU LYS SER SER LYS VAL SER GLU GLN LEU LYS SEQRES 3 A 131 CME CYS SER GLY ILE LEU LYS GLU MET PHE ALA LYS LYS SEQRES 4 A 131 HIS ALA ALA TYR ALA TRP PRO PHE TYR LYS PRO VAL ASP SEQRES 5 A 131 VAL GLU ALA LEU GLY LEU HIS ASP TYR CME ASP ILE ILE SEQRES 6 A 131 LYS HIS PRO MET ASP MET SER THR ILE LYS SER LYS LEU SEQRES 7 A 131 GLU ALA ARG GLU TYR ARG ASP ALA GLN GLU PHE GLY ALA SEQRES 8 A 131 ASP VAL ARG LEU MET PHE SER ASN CYS TYR LYS TYR ASN SEQRES 9 A 131 PRO PRO ASP HIS GLU VAL VAL ALA MET ALA ARG LYS LEU SEQRES 10 A 131 GLN ASP VAL PHE GLU MET ARG PHE ALA LYS MET PRO ASP SEQRES 11 A 131 GLU MODRES 5UOO CME A 356 CYS MODIFIED RESIDUE MODRES 5UOO CME A 391 CYS MODIFIED RESIDUE HET CME A 356 10 HET CME A 391 10 HET 8FV A 501 67 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM 8FV 7-(3,5-DIMETHYL-1,2-OXAZOL-4-YL)-6-METHOXY-2-METHYL-4- HETNAM 2 8FV (QUINOLIN-4-YL)-9H-PYRIMIDO[4,5-B]INDOLE FORMUL 1 CME 2(C5 H11 N O3 S2) FORMUL 2 8FV C26 H21 N5 O2 FORMUL 3 HOH *105(H2 O) HELIX 1 AA1 SER A 348 PHE A 365 1 18 HELIX 2 AA2 ALA A 366 LYS A 368 5 3 HELIX 3 AA3 HIS A 369 TRP A 374 1 6 HELIX 4 AA4 PRO A 375 TYR A 377 5 3 HELIX 5 AA5 ASP A 381 GLY A 386 1 6 HELIX 6 AA6 ASP A 389 ILE A 394 1 6 HELIX 7 AA7 ASP A 399 ALA A 409 1 11 HELIX 8 AA8 ASP A 414 ASN A 433 1 20 HELIX 9 AA9 HIS A 437 ALA A 455 1 19 LINK C LYS A 355 N CME A 356 1555 1555 1.34 LINK C CME A 356 N CYS A 357 1555 1555 1.35 LINK C TYR A 390 N CME A 391 1555 1555 1.35 LINK C CME A 391 N ASP A 392 1555 1555 1.35 SITE 1 AC1 13 TRP A 374 PRO A 375 PHE A 376 LEU A 385 SITE 2 AC1 13 LEU A 387 CYS A 429 TYR A 432 ASN A 433 SITE 3 AC1 13 HIS A 437 VAL A 439 MET A 442 HOH A 602 SITE 4 AC1 13 HOH A 666 CRYST1 52.188 72.793 32.117 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019161 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013738 0.000000 0.00000 SCALE3 0.000000 0.000000 0.031136 0.00000